申请人:Bristol-Myers Squibb Company
公开号:US20150315200A1
公开(公告)日:2015-11-05
The present invention provides compounds of Formula (I):
or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.
本发明提供公式(I)的化合物或立体异构体,其药学上可接受的盐,其中所有变量如此定义。这些化合物是XIa因子和/或血浆卡利肌酶的抑制剂,可用作药物。